The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group. [electronic resource]
Producer: 20030715Description: 1211-5 p. digitalISSN:- 1527-9995
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Drug Resistance, Neoplasm -- physiology
- Estramustine -- administration & dosage
- Feasibility Studies
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Neoplasm Recurrence, Local -- blood
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.